And Slowly But Surely..We Have Another 10-Bagger. PetVivo (PETV).
Things moving rather swimmingly at Pet-Vivo (PETV). Well, chart-wise.
REWARDS GO TO THE PATIENT?
Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.
Hapbee Announces Additions to Advisory Board
December 17, 2020
New Advisors Bring Decades of Entrepreneurial ExperienceWellness...
Hapbee (HAPB): The Netflix of Feelings
After 15 years, $70 million spent on R&D, and 350,000+ hours of testing, this "Netflix of Feelings" wearable technology is finally...
Aphex BioCleanse Systems (SNST) Signs European Supply and Private Label Agreement for DermAphex® and...
PITTSFORD, N.Y. , Dec. 16, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization solutions company focused on the development and distribution...
Mitesco (MITI) Expands ‘The Good Clinic’ to Colorado.
Mitesco Expands Footprint for The Good Clinic to Colorado at Lennar Multi-Family Developments to Serve as Stepping Stone to National Presence
Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.
My next guest, Scott Donnell, who is a serial entrepreneur and CEO of Hapbee (www.hapbee.com), had a knack for business early in...
BioSig (BSGM) Achieves First Commercial Sale of Three PURE EP Systems
Sale Marks Milestone for Company's Commercial expansion at leading Center of Excellence
Westport,...
Some Scientists Aren’t So Sure A Coronavirus Vaccine Will Come To The Rescue.
Pandemic-weary residents everywhere are holding their breath for the first coronavirus vaccines to be approved by federal regulators. The shots, currently being...
A Medical Technology That Has The Highest Potential Over Any We Follow.
You Must Read This...
New Report on the People Behind EMulate Therapeutics.
200 Million...
News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10.
Of course, approval news is the ultimate "as huge as it gets" news.
But at this stage...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
